President Donald Trump earlier this year bought as much as $680,000 in stock of Eli Lilly, the maker of blockbuster obesity drugs, as the agencies he oversees undertook an agenda that largely benefited the company. On May 14, the federal
News
Diagnostics
Innovation
Research
The Research category covers the latest medical studies, breakthroughs, and scientific advancements shaping the future of healthcare.

